IBSRELA
KNIGHT THERAPEUTICS INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of IBSRELA in Canada?
A shortage of IBSRELA 50MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated March 18, 2026), but it has not started yet.
When will IBSRELA be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02498049
Strength
50MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
TENAPANOR
Tier
Unrated
Last Updated
2026-03-18
Reason for Shortage
Other (Please describe in comments)
Other Products from KNIGHT THERAPEUTICS INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02468735
0.5MG · DIN 02381729
0.25MG · DIN 02381710
DIN 02332450
1G · DIN 02242980
DIN 02505223
400MG · DIN 02245828
30MG · DIN 02296152
DIN 02290308
25MG · DIN 01997602
20MG · DIN 01997572
5MG · DIN 01924516